| EP3229771 - 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.02.2025 Database last updated on 16.04.2026 | |
| Former | The patent has been granted Status updated on 01.03.2024 | ||
| Former | Grant of patent is intended Status updated on 24.10.2023 | ||
| Former | Examination is in progress Status updated on 19.10.2018 | ||
| Former | Request for examination was made Status updated on 15.09.2017 | ||
| Former | The international publication has been made Status updated on 05.06.2017 | Most recent event Tooltip | 13.03.2026 | Lapse of the patent in a contracting state New state(s): HU | published on 15.04.2026 [2026/16] | Applicant(s) | For all designated states Univerzita Palackého v Olomouci Krízkovského 8 771 47 Olomouc / CZ | [2017/42] | Inventor(s) | 01 /
DOLEZAL, Karel Posluchov 31 78365 Hlubocky / CZ | 02 /
PLIHALOVA, Lucie Za zahradami 393/19 783 01 Olomouc / CZ | 03 /
VYLICILOVA, Hana Dukelska 11 779 00 Olomouc / CZ | 04 /
ZATLOUKAL, Marek Revolucni 18a 78701 Sumperk / CZ | 05 /
PLIHAL, Ondrej Za zahradami 393/19 783 01 Olomouc / CZ | 06 /
VOLLER, Jiri Pristavni 1263/10B 635 00 Brno - Bystrc / CZ | 07 /
STRNAD, Miroslav Zapadni 25 77900 Olomouc / CZ | 08 /
BRYKSOVA, Magdalena Blazickova 20 779 00 Bystrovany / CZ | 09 /
VOSTALOVA, Jitka Kozusany 67 783 75 Kozusany - Tazaly / CZ | 10 /
RAJNOCHOVA SVOBODOVA, Alena Ksirova 1291/7 779 00 Olomouc / CZ | 11 /
ULRICHOVA, Jitka Nova Ulice Profesora Fuky 1279/16 779 00 Olomouc / CZ | 12 /
SPICHAL, Lukas Bystrocice 43 77900 Olomouc / CZ | [2023/47] |
| Former [2017/42] | 01 /
DOLEZAL, Karel Posluchov 31 78365 Hlubocky / CZ | ||
| 02 /
PLIHALOVA, Lucie Za zahradami 393/19 783 01 Olomouc / CZ | |||
| 03 /
VYLICILOVA, Hana Dukelska 11 779 00 Olomouc / CZ | |||
| 04 /
ZATLOUKAL, Marek Revolucni 18a 78701 Sumperk / CZ | |||
| 05 /
PLIHAL, Ondrej Handkeho 1a/757 779 00 Olomouc / CZ | |||
| 06 /
VOLLER, Jiri Pristavni 1263/10B 635 00 Brno - Bystrc / CZ | |||
| 07 /
STRNAD, Miroslav Zapadni 25 77900 Olomouc / CZ | |||
| 08 /
BRYKSOVA, Magdalena Blazickova 20 779 00 Bystrovany / CZ | |||
| 09 /
VOSTALOVA, Jitka Kozusany 67 783 75 Kozusany - Tazaly / CZ | |||
| 10 /
RAJNOCHOVA SVOBODOVA, Alena Ksirova 1291/7 779 00 Olomouc / CZ | |||
| 11 /
ULRICHOVA, Jitka Nova Ulice Profesora Fuky 1279/16 779 00 Olomouc / CZ | |||
| 12 /
SPICHAL, Lukas Bystrocice 43 77900 Olomouc / CZ | Representative(s) | Hartvichova, Katerina, et al HARBER IP s.r.o. Dukelskych hrdinu 567/52 170 00 Praha 7 / CZ | [2024/14] |
| Former [2017/42] | Hartvichova, Katerina Inventia s.r.o. Na Belidle 3 150 00 Praha 5 / CZ | Application number, filing date | 15774847.6 | 14.09.2015 | [2017/42] | WO2015CZ50005 | Priority number, date | CZ20140000875 | 09.12.2014 Original published format: CZ 20140875 | [2017/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016091235 | Date: | 16.06.2016 | Language: | EN | [2016/24] | Type: | A1 Application with search report | No.: | EP3229771 | Date: | 18.10.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2016 takes the place of the publication of the European patent application. | [2017/42] | Type: | B1 Patent specification | No.: | EP3229771 | Date: | 03.04.2024 | Language: | EN | [2024/14] | Search report(s) | International search report - published on: | EP | 16.06.2016 | Classification | IPC: | A61K8/60, A61Q17/04, A61Q19/08, A61K31/7076, C07H19/173, C07H19/19 | [2017/42] | CPC: |
C07H19/16 (EP,US);
A61K31/7076 (EP,CZ,US);
A61K8/606 (EP,CZ,US);
A61Q17/04 (EP,US);
A61Q19/08 (EP,US);
C07H19/173 (EP,CZ,US);
C07H19/19 (EP,CZ,US);
A61K31/7052 (US);
A61K31/7056 (US);
A61K31/706 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/42] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | 6-ARYL-9-GLYCOSYLPURINE UND VERWENDUNGEN DAVON | [2017/42] | English: | 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF | [2017/42] | French: | 6-ARYL-9-GLYCOSYLPURINES ET UTILISATION DE CELLES-CI | [2017/42] | Entry into regional phase | 05.06.2017 | National basic fee paid | 05.06.2017 | Designation fee(s) paid | 05.06.2017 | Examination fee paid | Examination procedure | 05.06.2017 | Examination requested [2017/42] | 05.06.2017 | Date on which the examining division has become responsible | 04.01.2018 | Amendment by applicant (claims and/or description) | 23.10.2018 | Despatch of a communication from the examining division (Time limit: M06) | 24.04.2019 | Reply to a communication from the examining division | 29.10.2019 | Despatch of a communication from the examining division (Time limit: M04) | 02.12.2019 | Reply to a communication from the examining division | 09.06.2020 | Despatch of a communication from the examining division (Time limit: M04) | 26.09.2020 | Reply to a communication from the examining division | 20.05.2021 | Despatch of a communication from the examining division (Time limit: M04) | 13.09.2021 | Reply to a communication from the examining division | 25.10.2023 | Communication of intention to grant the patent | 23.02.2024 | Fee for grant paid | 23.02.2024 | Fee for publishing/printing paid | 23.02.2024 | Receipt of the translation of the claim(s) | Opposition(s) | 06.01.2025 | No opposition filed within time limit [2025/11] | Fees paid | Renewal fee | 28.08.2017 | Renewal fee patent year 03 | 06.08.2018 | Renewal fee patent year 04 | 19.09.2019 | Renewal fee patent year 05 | 30.09.2020 | Renewal fee patent year 06 | 15.09.2021 | Renewal fee patent year 07 | 29.09.2022 | Renewal fee patent year 08 | 29.09.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 14.09.2015 | HU | 14.09.2015 | AT | 03.04.2024 | BG | 03.04.2024 | CZ | 03.04.2024 | DK | 03.04.2024 | EE | 03.04.2024 | ES | 03.04.2024 | FI | 03.04.2024 | HR | 03.04.2024 | IT | 03.04.2024 | LV | 03.04.2024 | MC | 03.04.2024 | NL | 03.04.2024 | PL | 03.04.2024 | RO | 03.04.2024 | SE | 03.04.2024 | SI | 03.04.2024 | SK | 03.04.2024 | SM | 03.04.2024 | NO | 03.07.2024 | RS | 03.07.2024 | GR | 04.07.2024 | IS | 03.08.2024 | PT | 05.08.2024 | GB | 14.09.2024 | IE | 14.09.2024 | LU | 14.09.2024 | BE | 30.09.2024 | CH | 30.09.2024 | FR | 30.09.2024 | [2026/16] |
| Former [2026/10] | CY | 14.09.2015 | |
| AT | 03.04.2024 | ||
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| IT | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SE | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| GB | 14.09.2024 | ||
| IE | 14.09.2024 | ||
| LU | 14.09.2024 | ||
| BE | 30.09.2024 | ||
| CH | 30.09.2024 | ||
| FR | 30.09.2024 | ||
| Former [2025/42] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SE | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| GB | 14.09.2024 | ||
| IE | 14.09.2024 | ||
| LU | 14.09.2024 | ||
| BE | 30.09.2024 | ||
| CH | 30.09.2024 | ||
| FR | 30.09.2024 | ||
| Former [2025/36] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| GB | 14.09.2024 | ||
| IE | 14.09.2024 | ||
| LU | 14.09.2024 | ||
| BE | 30.09.2024 | ||
| CH | 30.09.2024 | ||
| FR | 30.09.2024 | ||
| Former [2025/35] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| GB | 14.09.2024 | ||
| LU | 14.09.2024 | ||
| BE | 30.09.2024 | ||
| CH | 30.09.2024 | ||
| FR | 30.09.2024 | ||
| Former [2025/34] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| GB | 14.09.2024 | ||
| LU | 14.09.2024 | ||
| BE | 30.09.2024 | ||
| Former [2025/33] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| GB | 14.09.2024 | ||
| LU | 14.09.2024 | ||
| Former [2025/26] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| LU | 14.09.2024 | ||
| Former [2025/22] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| MC | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SI | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2025/10] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| RO | 03.04.2024 | ||
| SK | 03.04.2024 | ||
| SM | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2025/09] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| EE | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2025/08] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| DK | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2024/49] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| LV | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| PL | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| RS | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2024/48] | AT | 03.04.2024 | |
| BG | 03.04.2024 | ||
| CZ | 03.04.2024 | ||
| ES | 03.04.2024 | ||
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2024/47] | BG | 03.04.2024 | |
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| GR | 04.07.2024 | ||
| IS | 03.08.2024 | ||
| PT | 05.08.2024 | ||
| Former [2024/46] | BG | 03.04.2024 | |
| FI | 03.04.2024 | ||
| HR | 03.04.2024 | ||
| NL | 03.04.2024 | ||
| NO | 03.07.2024 | ||
| IS | 03.08.2024 | ||
| Former [2024/44] | NL | 03.04.2024 | Cited in | International search | [X] WO2012084173 (ROCHE DIAGNOSTICS GMBH et al.) | [X] US2008131952 (WU WEIDONG et al.) | [Y] WO2004058791 (USTAV EX BOTAN AKADEMIE VED CE et al.) | [X] EP2657246 (PUBLIC UNIV CORP YOKOHAMA CITY et al.) | [X] US6294522 (ZABLOCKI JEFF A et al.) [X] 5,6,8 * page 13, lines 12-16 * | [X] MICHAEL P. MCCRANE ET AL: "Oxidative Quenching of Quinone Methide Adducts Reveals Transient Products of Reversible Alkylation in Duplex DNA", CHEMICAL RESEARCH IN TOXICOLOGY, vol. 27, no. 7, 21 July 2014 (2014-07-21), US, pages 1282 - 1293, XP055224440, ISSN: 0893-228X, DOI: 10.1021/tx500152d DOI: http://dx.doi.org/10.1021/tx500152d | [X] WILLEM F. VELDHUYZEN ET AL: "Thermodynamic versus Kinetic Products of DNA Alkylation as Modeled by Reaction of Deoxyadenosine", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 123, no. 45, 1 November 2001 (2001-11-01), US, pages 11126 - 11132, XP055224505, ISSN: 0002-7863, DOI: 10.1021/ja011686d DOI: http://dx.doi.org/10.1021/ja011686d | [X] SAKO M. ; ISHIKURA H. ; HIROTA K. ; MAKI Y.: "A newly devised method for the debenzylation of N6-benzyladenosines. A convenient synthesis of [6-15N]-labeled adenosines", NUCLEOSIDES AND NUCLEOTIDES, vol. 13, no. 6&7, 1994, pages 1239 - 1246, XP009186954, ISSN: 0732-8311, DOI: 10.1080/15257779408012148 DOI: http://dx.doi.org/10.1080/15257779408012148 | Examination | KAREL DOLEŽAL ET AL: "Preparation, biological activity and endogenous occurrence of N6-benzyladenosines", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, no. 11, 1 June 2007 (2007-06-01), pages 3737 - 3747, XP055103745, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2007.03.038 [X] 5-8 * page 3739; table 1 * DOI: http://dx.doi.org/10.1016/j.bmc.2007.03.038 | GONZALEZ M P ET AL: "A radial distribution function approach to predict A"2"B agonist effect of adenosine analogues", BIOORGANIC & MEDICINAL CHEMI, PERGAMON, GB, vol. 13, no. 3, 1 February 2005 (2005-02-01), pages 601 - 608, XP004710824, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2004.10.063 [X] 5-8 * page 604; table 6 * DOI: http://dx.doi.org/10.1016/j.bmc.2004.10.063 | NOBUO SAKAIRI ET AL: "Chemical Conversion of Some Ribonucleosides into the Corresponding a-d-Arabinofuranosyl Derivatives", NUCLEOSIDES AND NUCLEOTIDES, vol. 2, no. 3, 19 January 1983 (1983-01-19), US, pages 221 - 229, XP055575873, ISSN: 0732-8311, DOI: 10.1080/07328318308078856 DOI: http://dx.doi.org/10.1080/07328318308078856 | by applicant | BARAI ET AL., VESTSI AKADEMII NAUK BELARUSI, vol. 1, 1992, pages 18 - 22 | MARUYAMA ET AL., CHEM. PHARM. BULL., vol. 44, 1996, pages 2331 - 2334 | MASAKATSU ET AL., CHEM. PHARM. BULL., vol. 25, 1977, pages 2482 - 2489 | KOSZALKA ET AL., ARITIMIEROB. AGENTS CHEMOTHER, vol. 35, 1991, pages 1437 - 1443 | SPIELMANN H; BALLS M; DUPUIS J; PAPE WJ; PECHOVITCH G; DE SILVA 0; HOLZHIITTER HG; CLOTHIER R; DESOLLE P; GERBERICK F, TOXICOL IN VITRO, vol. 12, no. 3, 1 June 1998 (1998-06-01), pages 305 - 27 | SPIELMANN H; BALLS M; DUPUIS J; PAPE J; PECHOVITCH G; DE SILVA 0; HOLZHTTER HG; CLOTHIER R; DESOLLE P; ERBERICK F, TOXICOL IN VITRO., vol. 12, no. 3, 1 June 1998 (1998-06-01), pages 305 - 27 |